Skip to main content

misoprostol (Angusta®)

 

Status: Medicine does not meet criteria for AWMSG assessment

Excluded from appraisal by AWMSG as meets exclusion criterion 6. See AWMSG criteria for appraising a medicine for information.

Medicine details

Medicine name misoprostol (Angusta®)
Formulation 25 microgram tablet
Reference number 4624
Indication

Induction of labour

Company Norgine Pharmaceuticals Ltd
BNF chapter Obstetrics, gynaecology & urinary tract disorders
Submission type N/A
Status Medicine does not meet criteria for AWMSG assessment
Date of issue 07/04/2021
Follow AWTTC: